Skip navigation
Skip navigation

Th2-mediated anti-tumour immunity: Friend or foe?

Ellyard, Julia; Simson, Ljubov; Parish, Christopher


The concept that the immune system can recognise tumour cells and either eliminate them (tumour immune surveillance) or select for immunologically resistant variants (immunoediting) is gaining general acceptance by immunologists. In terms of an adaptive immune response to cancer, however, much of the research has focused on the response of cytotoxic CD8+ T lymphocytes to tumour-specific antigens and the production of Th1 cytokines by CD4+ and CD8+ T cells. In contrast, Th2-mediated immunity has...[Show more]

CollectionsANU Research Publications
Date published: 2007
Type: Journal article
Source: Tissue Antigens
DOI: 10.1111/j.1399-0039.2007.00869.x


File Description SizeFormat Image
01_Ellyard_Th2-mediated_anti-tumour_2007.pdf261.49 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  20 July 2017/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator